CD68 and breast carcinoma: The fact that the TRIB3-AKT1 interaction prohibits the AKT1-FOXO1 interaction provides an opportunity to modulate the effects of the niche-enriched stress protein TRIB3, which indeed shows enhanced expression adjacent to CD68+ TAMs in breast cancer patients.